Patel Sushil sold RVMD

June 29, 2026 · Form 4 insider transaction

Patel Sushil sold 541 shares of Revolution Medicines, Inc. at $191.87 per share, a transaction worth $103.8K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Disposed (sell-side)
Shares
541
Price
$191.87
Total value
$103.8K
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJune 29, 2026
Filing dateJuly 1, 2026
Shares owned after22,537
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Transaction made pursuant to a 10b5-1 trading plan adopted by Sushil Patel on March 30, 2026.; The transaction was executed in multiple trades in prices ranging from $191.47 to $192.40, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.; Includes 1,191 restricted stock units.

View the original Form 4 on SEC EDGAR